/DH

DH Stock - Definitive Healthcare Corp.

Q: What is the analyst price target for DH?

Analyst price target information is not currently available for DH.

Q: What is DH's market cap?

Market capitalization information is not currently available for DH.

Healthcare|Medical - Healthcare Information Services|NASDAQ

$2.47-2.76%

$0.07 (-2.76%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+26.7%upside

Target: $3.13

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.60

52W High$5.68

52W Low$2.15

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$252.20M	$251.41M	$222.65M	$166.15M	$118.32M
Gross Profit	$197.47M	$203.93M	$180.03M	$125.47M	$87.85M
Gross Margin	78.3%	81.1%	80.9%	75.5%	74.2%
Operating Income	$-710,820,000	$-329,800,000	$-44,043,000	$-27,317,000	$-15,886,000
Net Income	$-413,124,000	$-202,388,000	$-7,222,000	$-51,908,000	$-52,598,000
Net Margin	-163.8%	-80.5%	-3.2%	-31.2%	-44.5%
EPS	$-3.54	$-1.79	$-0.07	$-0.19	$-0.53

Company Overview

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Visit Website

Earnings History & Surprises

Beat Rate

71%

Last 17 quarters

Avg Surprise

+27.9%

EPS vs Estimate

Beats / Misses

12/2

3 met exactly

Latest EPS

$0.07

Q4 2025

EPS Surprise History

Q1 24

0.0%

$0.07vs$0.07

Q2 24

0.0%

$0.08vs$0.08

Q3 24

0.0%

$0.09vs$0.09

Q4 24

+25.0%

$0.10vs$0.08

Q1 25

+14.3%

$0.08vs$0.07

Q2 25

+150.0%

$0.05vs$0.02

Q3 25

+40.0%

$0.07vs$0.05

Q4 25

+16.7%

$0.07vs$0.06

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Feb 26, 2026	$0.06	—	—	—
Q4 2025	Nov 6, 2025	$0.06	$0.07	+16.7%	✓ BEAT
Q3 2025	Aug 7, 2025	$0.05	$0.07	+40.0%	✓ BEAT
Q2 2025	May 8, 2025	$0.02	$0.05	+150.0%	✓ BEAT
Q1 2025	Feb 27, 2025	$0.07	$0.08	+14.3%	✓ BEAT
Q4 2024	Nov 7, 2024	$0.08	$0.10	+25.0%	✓ BEAT
Q3 2024	Aug 5, 2024	$0.09	$0.09	0.0%	= MET
Q2 2024	May 7, 2024	$0.08	$0.08	0.0%	= MET
Q1 2024	Feb 28, 2024	$0.07	$0.07	0.0%	= MET
Q4 2023	Nov 2, 2023	$0.06	$0.09	+50.0%	✓ BEAT
Q3 2023	Aug 14, 2023	$0.05	$0.08	+60.0%	✓ BEAT
Q2 2023	May 4, 2023	$0.05	$0.06	+20.0%	✓ BEAT
Q1 2023	Feb 23, 2023	$0.04	$0.07	+67.7%	✓ BEAT
Q4 2022	Nov 3, 2022	$0.05	$0.06	+20.0%	✓ BEAT
Q3 2022	Aug 4, 2022	$0.05	$0.06	+20.0%	✓ BEAT
Q2 2022	May 5, 2022	$0.03	$0.05	+44.9%	✓ BEAT
Q1 2022	Feb 23, 2022	$0.04	$0.04	-7.4%	✗ MISS
Q4 2021	Nov 8, 2021	$0.02	$0.01	-47.4%	✗ MISS
Q3 2021	Sep 16, 2021	—	$-0.12	—	—

Frequently Asked Questions about DH

What is DH's current stock price?

Definitive Healthcare Corp. (DH) is currently trading at $2.47 per share. The stock has moved -2.76% today.

What is the analyst price target for DH?

The average analyst price target for DH is $3.13, based on 1 analyst.

What sector is Definitive Healthcare Corp. in?

Definitive Healthcare Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.

What is DH's market cap?

Definitive Healthcare Corp. has a market capitalization of $0.26 billion, making it a small-cap company.

Does DH pay dividends?

No, Definitive Healthcare Corp. does not currently pay a dividend to shareholders.